Das ist Gut! Germany Attracts $6.5 Billion in Pharma-Biotech Capex Investment
Das ist Gut! Germany Attracts $6.5 Billion in Pharma-Biotech Capex Investment
Attachment: Active Pharma-Bio Projects in Europe
SUGAR LAND--April 14, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)-Germany is an essential part of the Pharmaceutical-Biotech Industry, home to Europe's largest pharmaceutical market, and landing fourth on a global level with its market share of 13.5% in 2016. Its industry prominence is reflected in the $6.5 billion in active reported capital projects, divided among 160 individual projects.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects